IA
IMUX icon

IFP Advisors’s Immunic IMUX Stock Holding History

IFP Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-200
Closed -$5.02K – 3430
2023
Q2 		$5.02K Buy
+200
New +$3.35K ﹤0.01% 2544

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

IFP Advisors's IMUX Position: Q3 2023 in Review

IFP Advisors sold out of Immunic (IMUX) in Q3 2023, closing a stake of 200 shares — an estimated $5.02K sold.

IFP Advisors first reported a position in IMUX in Q2 2023 and held it in 1 quarter. The position peaked at $5.02K in Q2 2023. 53 funds tracked by Wall St. Rank hold IMUX as of Q3 2023.

  • IFP Advisors reported no remaining Immunic position as of Q3 2023 after selling out during the quarter.
  • IFP Advisors sold 200 Immunic shares in Q3 2023, an estimated $5.02K.
  • IFP Advisors first reported a position in Immunic in Q2 2023 and held it in 1 quarter.
  • IFP Advisors's Immunic position peaked at $5.02K in Q2 2023.
  • 53 funds tracked by Wall St. Rank held Immunic as of Q3 2023.

Based on IFP Advisors's 13F filing for Q3 2023, filed 12 Oct 2023.